SMAD3 and renal fibrosis: In addition, strategy targeting rebalancing TGF-β/Smad3/Smad7 signaling in vivo has been demonstrated to be effective for reducing renal fibrosis in obstructive nephropathy (Chung et al., 2013; Zhou et al., 2016).